Physician

Ryan Char Kelm

According to 2025 Medicare claims, Ryan Kelm (NPI: 1043772627) practices dermatology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is CHESNUT MD (NPI: 1437798568; TIN: 844125494) and primary practice location at 99202-1332.

Kelm's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 53 traditional Medicare patients, billed 145 HCPCS/CPT codes, and received $35,813 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 124 prescription claims across 74 beneficiaries totaling $2,495 in drug costs, led by Ondansetron Hcl (Ondansetron Hcl). Open Payments data shows 2 records totaling $226. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $848 to $2,495. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$18K$36K2024 Medicare payment: $35,813 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202453145$35,813

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$68K$137K2019 Drug cost: $848 (USD; Tot_Drug_Cst)2020 Drug cost: $2,651 (USD; Tot_Drug_Cst)2021 Drug cost: $136,678 (USD; Tot_Drug_Cst)2022 Drug cost: $124,395 (USD; Tot_Drug_Cst)2023 Drug cost: $28,929 (USD; Tot_Drug_Cst)2024 Drug cost: $2,495 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R11$848
20202037$2,651
202159109$136,678
202294220$124,395
202360108$28,929
202474124$2,495

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2121$71
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more1212$45
17000Destruction of precancer skin growth, 1 growth1111$45

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ondansetron HclOndansetron Hcl821,271$550
OmeprazoleOmeprazole11154$47

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$226Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan Char Kelm?

Tedicare shows public-source Medicare data for Ryan Char Kelm (NPI 1043772627), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Char Kelm have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Char Kelm?

Ryan Char Kelm is linked to CHESNUT MD (billing NPI 1437798568) in the available physician profile data.

Does Ryan Char Kelm have Open Payments data?

Ryan Char Kelm has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.